|1.||Fink, Ludger: 2 articles (05/2009 - 12/2003)|
|2.||Haberbosch, Werner: 2 articles (05/2009 - 12/2003)|
|3.||Walker, Gerhard: 2 articles (05/2009 - 12/2003)|
|4.||Packham, Graham: 1 article (05/2011)|
|5.||Crabb, Simon J: 1 article (05/2011)|
|6.||Hayden, Annette: 1 article (05/2011)|
|7.||Johnson, Peter W M: 1 article (05/2011)|
|8.||Tillmanns, Harald: 1 article (05/2009)|
|9.||Langheinrich, Alexander C: 1 article (05/2009)|
|10.||Tröbs, Monique: 1 article (05/2009)|
12/31/2000 - "Induction of apoptosis in human leukemia cells by 3-deazaadenosine is mediated by caspase-3-like activity."
06/01/1994 - "The effect of exogenous homocysteine thiolactone (Hcy) on apoptosis initiated by 3-deazaadenosine (c3Ado) was studied in human leukemia HL-60 cells. "
12/03/1993 - "Cell death initiated by the adenosine analog 3-deazaadenosine (c3 Ado) was studied in human promyelocytic leukemia HL-60 cells. "
10/09/1991 - "Effects of the transmethylation inhibitors 3-deazaadenosine (c3Ado) and 3-deaza-(+/-)-aristeromycin (c3Ari) on cell cycle and cyclic AMP (cAMP) concentrations in human promyelocytic leukemia cells (HL-60) were studied by flow cytometry and radioimmunoassay techniques. "
01/01/1996 - "The extent- and cell cycle specificity of apoptotic cell death were studied in human leukemia HL-60 cells treated with 1.25-20 mu M etoposide, 0.125-2.0 mu g/ml dactinomycin, 12.5-200 mu M 3-deazaadenosine (c(3)Ado) and 10-50 Gy gamma-irradiation. "
03/01/1983 - "The carbocyclic analog of 3-deazaadenosine (C-c3 Ado) was found to inhibit in vitro the replication of several DNA and RNA viruses, including vaccinia, reo, measles, parainfluenza and vesicular stomatitis, at a concentration of 0.2-1 microgram/ml, while not being toxic for the host (primary rabbit kidney, HeLa, Vero) cells at a concentration of 400 micrograms/Ml. In its activity against vesicular stomatitis virus, parainfluenza virus, measles and reo virus, C-c3 Ado proved about 100 times more potent than other established broad-spectrum antiviraL agents such as ribavirin (virazole) and (S)-DHPA ((S)-9-(2,3-dihydroxypropyl)adenine). "
03/05/1992 - "Activation of collagen IV gene expression in F9 teratocarcinoma cells by 3-deazaadenosine analogs. "
03/05/1992 - "F9 teratocarcinoma cells, stably transfected with two collagen (IV) promoter-enhancer-CAT constructs and treated with 10 microM 3-deazaadenosine, 3-deaza-(+-)-aristeromycin or 3-deazaneplanocin, showed a strong induction of CAT activities without affecting differentiation. "
|7.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|10.||Immunoglobulin E (IgE)